OR11J5P

Across TCGA pan-cancer cohorts, OR11J5P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated OR11J5P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher OR11J5P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR11J5P expression acts as an unfavorable survival marker.

STAD, BLCA, and LUSC are the cancer types where OR11J5P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	II,III,IV	0.359	0.682	<.001	126	view →
BLCA	OS	Tertile	All	0.251	0.711	.002	45	view →
LUSC	OS	Tertile	II,III,IV	0.259	0.633	.018	45	view →
KICH	DFS	Tertile	All	0.102	0.848	.004	39	view →
LGG	DFS	Tertile	All	0.089	0.845	<.001	18	view →
HNSC	DFS	Tertile	All	0.315	0.629	.036	9	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

OR11J5P–STAD (OS)

Open the STAD breakdown →